Supreme Court Holds That “Pay for Delay” Pharmaceutical Patent Settlements May Violate the Antitrust Laws
By James M. BurnsOn June 17, the United States Supreme Court issued its highly-anticipated decision in FTC v. Actavis Inc., a case with significant implications for patent law, antitrust law and healthcare law. The case...
Read More